Browse > Article
http://dx.doi.org/10.3344/kjp.2009.22.1.104

The Effect of Thalidomide on Entero-Behcet's Disease  

Kim, Jung Hak (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Nam, Voki (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Moon, Ho Sik (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Kim, Jin Ook (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Sung, Choon Ho (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Publication Information
The Korean Journal of Pain / v.22, no.1, 2009 , pp. 104-106 More about this Journal
Abstract
Behcet's disease is a chronic relapsing vasculitis characterized by recurrent aphthous oral and genital ulcers with uveitis. Multiple organs can be involved. Entero-Behcet's disease is often uncontrollable, relapsing, and can cause acute intestinal bleeding, fistula formation, or perforation. Corticosteroids, immunosuppressors, and colchicines are used to treat Entero-Behcet's disease with varying degree of success. Thalidomide may also be feasible. We present a 29-year-old male Entero-Behcet's patient suffering from abdominal pain, diarrhea, and back pain. He did not respond to prior treatments, but responded to thalidomide.
Keywords
abdominal pain; Behcet's disease; thalidomide;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 1999; 341: 1284-91   DOI   ScienceOn
2 Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T: Intestinal involvement in Behcet's disease:review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 1981; 24: 103-6   DOI   ScienceOn
3 Kotter I, Durk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M: Therapy of Behcet's disease. Ger J Ophthalmol 1996; 5: 92-7   PUBMED   ScienceOn
4 Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965; 6: 303-6   DOI
5 Lee CK, Kim HJ: Pathogenesis and Treatment of Intestinal Behcet's disease. Korean J Gastroenterol 2007; 50: 3-8
6 Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH: HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19(Suppl): 31-5
7 Hamza MH: Treatment of Behcet's disease with thalidomide. Clin Rheumatol 1986; 5: 365-71   DOI   PUBMED   ScienceOn
8 Dilsen N: History and development of Behcet's disease. Rev Rhum Engl Ed 1996; 63: 512-9   PUBMED   ScienceOn
9 Eglin RP, Lehner T, Subak-Sharpe JH: Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982; 2: 1356-61   DOI   PUBMED   ScienceOn
10 Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G: Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80   DOI   PUBMED   ScienceOn
11 Saylan T, Saltik I: Thalidomide in the treatment of Behcet's syndrome. Arch Dermatol 1982; 118: 536   DOI   ScienceOn
12 Larsson H: Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217). J Intern Med 1990; 228: 405-7   DOI   PUBMED   ScienceOn
13 Chang HK: Treatment of Behcet's disease. J Korean Rheum Assoc 2003; 10: 101-10
14 Whitehead R, Gratama S: Gastrointestinal and esophageal pathology. 2nd ed. New York, Churchill Livingstone. 1995, pp 687-709
15 Pacor ML, Biasi D, Lunardi C, Cortina P, Caramaschi P, Girelli D, et al: Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 1994; 13: 224-7   PUBMED
16 Suzuki Kurokawa M, Suzuki N: Behcet's disease. Clin Exp Med 2004; 4: 10-20   DOI   ScienceOn
17 Yoshikawa K, Kotake S, Sasamoto Y, Ohno S, Matsuda H: Close association of Streptococcus sanguis and Behcet's disease. Nippon Ganka Gakkai Zasshi 1991; 95: 1261-7   PUBMED
18 Houman MH, Hamzaoui K: Promising new therapies for Behcet's disease. Eur J Intern Med 2006; 17: 163-9   DOI   ScienceOn